Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $110,680 | 50 | 63.3% |
| Consulting Fee | $27,525 | 11 | 15.8% |
| Food and Beverage | $20,256 | 889 | 11.6% |
| Travel and Lodging | $12,756 | 59 | 7.3% |
| Honoraria | $2,750 | 2 | 1.6% |
| Education | $775.61 | 12 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $83,453 | 150 | $0 (2024) |
| Celgene Corporation | $42,676 | 58 | $0 (2019) |
| PFIZER INC. | $25,043 | 117 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $6,479 | 32 | $0 (2024) |
| Aqua Pharmaceuticals | $2,972 | 9 | $0 (2017) |
| Allergan, Inc. | $2,192 | 6 | $0 (2022) |
| Janssen Biotech, Inc. | $1,993 | 145 | $0 (2024) |
| GENZYME CORPORATION | $1,334 | 46 | $0 (2024) |
| ABBVIE INC. | $1,286 | 57 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $726.57 | 41 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25,652 | 116 | Amgen Inc. ($17,776) |
| 2023 | $49,170 | 154 | Amgen Inc. ($47,436) |
| 2022 | $6,406 | 82 | Amgen Inc. ($4,848) |
| 2021 | $5,500 | 108 | Amgen Inc. ($3,836) |
| 2020 | $10,465 | 85 | Amgen Inc. ($9,394) |
| 2019 | $21,933 | 173 | Celgene Corporation ($16,137) |
| 2018 | $22,748 | 117 | Celgene Corporation ($12,286) |
| 2017 | $32,870 | 188 | Celgene Corporation ($14,252) |
All Payment Transactions
1,023 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $10.56 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.60 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: Immunology | ||||||
| 11/21/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.45 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: DERMATOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: IMMUNOLOGY | ||||||
| 10/12/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $21.39 | General |
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Dermatology | ||||||
| 10/03/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $5.03 | General |
| Category: DERMATOLOGY | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.56 | General |
| Category: Immunology | ||||||
| 10/02/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $8.37 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.06 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/26/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Dermatology | ||||||
| 09/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 09/17/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: DERMATOLOGY | ||||||
| 09/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $10.16 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,170 | 2,570 | $307,397 | $114,258 |
| 2022 | 15 | 1,068 | 2,364 | $264,644 | $101,946 |
| 2021 | 16 | 1,107 | 2,540 | $316,068 | $123,631 |
| 2020 | 15 | 992 | 2,330 | $260,476 | $94,267 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 307 | 429 | $67,530 | $25,760 | 38.1% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 28 | 31 | $30,225 | $17,633 | 58.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 219 | 298 | $37,548 | $12,585 | 33.5% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 13 | 28 | $27,300 | $10,291 | 37.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 93 | 112 | $19,600 | $8,454 | 43.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 43 | 58 | $25,056 | $8,193 | 32.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 68 | 80 | $14,400 | $7,127 | 49.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 183 | 1,249 | $34,972 | $6,848 | 19.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 59 | 59 | $11,940 | $4,891 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 39 | $7,920 | $3,689 | 46.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 74 | 104 | $14,976 | $3,071 | 20.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 22 | $7,128 | $2,760 | 38.7% |
| 13131 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm | Office | 2023 | 13 | 13 | $6,786 | $2,233 | 32.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 11 | 16 | $1,440 | $705.21 | 49.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 32 | $576.00 | $17.22 | 3.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 257 | 404 | $51,975 | $23,643 | 45.5% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 21 | 24 | $23,400 | $13,762 | 58.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 188 | 267 | $33,768 | $10,640 | 31.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 43 | 65 | $28,080 | $9,333 | 33.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 82 | 103 | $18,540 | $9,181 | 49.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 89 | 112 | $18,439 | $8,209 | 44.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 163 | 1,059 | $29,624 | $5,801 | 19.6% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 11 | 15 | $14,625 | $5,549 | 37.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 74 | 125 | $18,000 | $3,880 | 21.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 21 | 29 | $9,396 | $3,812 | 40.6% |
About Dr. Michael Bradshaw, M.D
Dr. Michael Bradshaw, M.D is a Dermatology healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/11/2008. The National Provider Identifier (NPI) number assigned to this provider is 1861646267.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Bradshaw, M.D has received a total of $174,743 in payments from pharmaceutical and medical device companies, with $25,652 received in 2024. These payments were reported across 1,023 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($110,680).
As a Medicare-enrolled provider, Bradshaw has provided services to 4,337 Medicare beneficiaries, totaling 9,804 services with total Medicare billing of $434,102. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location San Diego, CA
- Active Since 11/11/2008
- Last Updated 10/26/2016
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1861646267
Products in Payments
- Otezla (Drug) $125,867
- EUCRISA (Drug) $23,926
- ACZONE (Drug) $2,137
- DUPIXENT (Biological) $1,498
- Tremfya (Drug) $804.37
- TREMFYA (Drug) $790.31
- Sotyktu (Drug) $572.67
- Humira (Biological) $507.70
- OPZELURA (Drug) $481.39
- SKYRIZI (Biological) $415.00
- TALTZ (Drug) $387.66
- Trianex (Drug) $350.00
- RINVOQ (Biological) $344.14
- ENSTILAR (Drug) $253.56
- DUPIXENT DUPILUMAB INJECTION (Biological) $220.35
- Seysara (Drug) $216.19
- VTAMA (Drug) $215.84
- Bimzelx (Biological) $215.59
- Cordran (Drug) $205.32
- ILUMYA (Biological) $203.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in San Diego
Dr. Sabrina Fabi, M.d, M.D
Dermatology — Payments: $3.3M
Neal Bhatia, Md, MD
Dermatology — Payments: $2.6M
Dr. Arisa Ortiz, M.d, M.D
Dermatology — Payments: $354,946
Dr. Dawn Eichenfield, M.d., Ph.d, M.D., PH.D
Dermatology — Payments: $179,796
Dr. Tissa Hata, M.d, M.D
Dermatology — Payments: $138,047
Dr. David Chu, M.d, M.D
Dermatology — Payments: $96,502